Thrombin

Thông tin thuốc gốc
Chỉ định và Liều dùng
Topical/Cutaneous
Aid to haemostasis when bleeding from capillaries and small venules
Adult: In cases where oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard surgical techniques (e.g. cautery, suture, ligature) is ineffective or impractical: As human-derived or recombinant solution: Apply directly or in conjunction with absorbable gelatine sponge onto the bleeding site. Dose depends on the size of the bleeding area. As bovine-derived solution: Apply 1,000-2,000 international units/mL for profuse bleeding or 100 international units/mL for bleeding from skin or mucosal surfaces. As bovine-derived powder: Apply directly onto the bleeding sites. Dosing recommendations and methods of application may vary among individual products (refer to specific product guidelines).
Child: ≥1 month In cases where oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard surgical techniques (e.g. cautery, suture, ligature) is ineffective or impractical: As recombinant solution: Apply directly or in conjunction with absorbable gelatine sponge onto the bleeding site. Dose depends on the size of the bleeding area. Dosing recommendations and methods of application may vary among individual products (refer to specific product guidelines).
Hướng dẫn pha thuốc
Instructions for reconstitution may vary among individual products and methods of application (refer to specific product guidelines).
Chống chỉ định
History of hypersensitivity to thrombin or other human blood products. Severe or brisk arterial bleeding treatment. Administration directly into the circulatory system. Bovine thrombin: Known or suspected antibodies to bovine thrombin and/or factor V.
Thận trọng
Children. Pregnancy and lactation.
Tác dụng không mong muốn
Significant: Hypersensitivity reactions (e.g. anaphylaxis), risk of infection transmission.
Blood and lymphatic system disorders: Anaemia, thrombocytopenia.
Investigations: Prolonged aPTT or prothrombin time, increased INR, increased neutrophil count, decreased lymphocyte count.
Cardiac disorders: Tachycardia.
Vascular disorders: Hypotension.
Potentially Fatal: Severe bleeding or thrombosis (bovine thrombin).
Chỉ số theo dõi
Monitor for signs of hypersensitivity, bleeding, thrombosis and abnormal coagulation laboratory values.
Tác dụng
Description:
Mechanism of Action: Thrombin is a protein substance produced from prothrombin. It catalyses the conversion of soluble fibrinogen into insoluble fibrin to promote haemostasis.
Bảo quản
Store between 2-25°C. Do not freeze. Storage recommendations may vary among individual products (refer to specific product guidelines).
Phân loại MIMS
Thuốc cầm máu
Phân loại ATC
B02BC06 - thrombin ; Belongs to the class of local hemostatics. Used in the treatment of hemorrhage.
B02BD30 - thrombin ; Belongs to the class of blood coagulation factors. Used in the treatment of hemorrhage.
Tài liệu tham khảo
Anon. Thrombin (Bovine). AHFS Clinical Drug Information [online]. Bethesda, MD. American Society of Health-System Pharmacists, Inc. https://www.ahfscdi.com. Accessed 23/01/2024.

Anon. Thrombin (Human). AHFS Clinical Drug Information [online]. Bethesda, MD. American Society of Health-System Pharmacists, Inc. https://www.ahfscdi.com. Accessed 22/03/2023.

Anon. Thrombin (Topical). Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 24/01/2024.

Buckingham R (ed). Thrombin. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 22/03/2023.

Recothrom (Baxter Healthcare Corporation). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed. Accessed 23/01/2024.

Thrombin Human Powder, for Solution (Ethicon, Inc). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed. Accessed 22/03/2023.

Thrombin-JMI (Pfizer Laboratories Div Pfizer Inc). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed. Accessed 23/01/2024.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Thrombin từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2026 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi MIMS.com